Eagle Pharmaceuticals (EGRX) executive Tarriff sold 15,000 shares for $300K at $19.98

Insider transactions reported

Scott Tarriff (executive at Eagle Pharmaceuticals Inc., EGRX) reported that they sold 15,000 shares for $300K at $19.98 on May 16, 2023. After these transactions the filing shows 587,311 shares held directly.

Reporting person

Tarriff Scott

Holdings before and after

• Common Stock: 602,311 to 587,311 direct

Other positions listed

• Common Stock: 992,623 indirect, By Tarriff 2016 Generation Skipping Exempt Family Trust DTD 12/28/2016

Footnotes from the filing

1. 1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.7454 to $20.53 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. 2. This report reflects an adjustment to the Reporting Person's direct holdings to exclude shares incorrectly included in prior reports as directly held and to reflect such shares as held indirectly through the Tarriff 2016 Generation Skipping Exempt Family Trust DTD 12/28/2016 (the Trust ).
3. 3. The shares are held by the Trust for the benefit of the Reporting Person's spouse and children. The Reporting Person does not have investment control over the shares held by the Trust and disclaims beneficial ownership of the shares, except to any pecuniary interest therein, if any.

Transaction codes in this filing

Open-market sale:

Code S marks a sale in the open market or a private deal. The insider received cash for these securities.

FAQ